Belgian Firm Launches $1,990 DTC Clinical Exome Test; Focus on Carrier Screening, PGx | GenomeWeb

Belgian startup Gentle started offering a direct-to-consumer clinical exome sequencing test last week that focuses on carrier screening for more than 1,700 severe genetic diseases, including risk assessment for a number of adult-onset disorders, as well as pharmacogenomic markers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.